Menu

Recent 340B commentary and research included: a new report on rebate model comments, two policy proposals and Maryland's prescription drug affordability board's study on 340B in the state.

340B Research Roundup: Large Disparity in Rebate Comments, Two Policy Proposals, Maryland PDAB 340B Report

July 23, 2026 Luke Zarzecki, National Correspondent 340B Report Views

Editor’s Note: As the 340B program draws increased attention from researchers, policymakers and commentators, 340B Report has launched a new [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a paid subscriber, please follow the steps below.

Please be sure you’ve completed your one-minute subscription completion form.
I have read and accepted the terms of use and privacy policy.
Log In!

If you are not yet a paid subscriber, please Subscribe now

For questions about subscriptions or technical assistance, please contact Reshma Eggleston at reshma.eggleston@340breport.com.

Luke Zarzecki

Arkansas Sues 13 Drugmakers, Second Sight Over 340B Restrictions and Data Reqs

340B Lobbying Stayed Strong in 2nd Quarter of 2026